Journal:PMC:1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 11: Line 11:
====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.====
====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.====
-
<scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. <scene name='Journal:PMC:1/Cv1/5'>Naltrexone with a bulkier side chain</scene> is more antagonistic than Naloxone.
+
<scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. <scene name='Journal:PMC:1/Cv1/5'>Naltrexone with a bulkier side chain</scene> is more antagonistic than Naloxone. In humans, <scene name='Journal:PMC:1/Cv1/6'>Alvimopam is an antagonist and there is significant hindrance of the piperidine ring by the second aromatic ring</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(in yellow)</span>.
</StructureSection>
</StructureSection>

Revision as of 08:03, 23 November 2011

Drag the structure with the mouse to rotate
  1. Joel S. Goldberg, Perspectives in Medicinal Chemistry 2010:4 1-10, Stereochemical Basis for a Unified Structure Activity Theory of Aromatic and Heterocyclic Rings in Selected Opioids and Opioid Peptides doi:http://dx.doi.org/10.4137/PMC.S3898

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools